294 related articles for article (PubMed ID: 36970592)
1. Systemic treatment for metastatic colorectal cancer.
Leowattana W; Leowattana P; Leowattana T
World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
[TBL] [Abstract][Full Text] [Related]
2. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
Atreya CE; Yaeger R; Chu E
Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
[TBL] [Abstract][Full Text] [Related]
3. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of metastatic colorectal cancer in the era of precision medicine.
Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
[TBL] [Abstract][Full Text] [Related]
5. The current status and prospect of immunotherapy in colorectal cancer.
Shu Y; Zheng S
Clin Transl Oncol; 2024 Jan; 26(1):39-51. PubMed ID: 37301804
[TBL] [Abstract][Full Text] [Related]
6. The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.
Taieb J; Jung A; Sartore-Bianchi A; Peeters M; Seligmann J; Zaanan A; Burdon P; Montagut C; Laurent-Puig P
Drugs; 2019 Sep; 79(13):1375-1394. PubMed ID: 31347092
[TBL] [Abstract][Full Text] [Related]
7. Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer.
Underwood PW; Ruff SM; Pawlik TM
Cells; 2024 Jan; 13(3):. PubMed ID: 38334637
[TBL] [Abstract][Full Text] [Related]
8. Genomic landscape of treatment refractory metastatic colorectal cancer.
Eefsen RL; Simonsen KS; Grundtvig P; Klarskov L; Chen IM; Høgdall D; Jensen BV; Lorentzen T; Poulsen TS; Theile S; Nielsen D; Høgdall E
Acta Oncol; 2021 Dec; 60(12):1621-1628. PubMed ID: 34606390
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
Lonardi S; Nimeiri H; Xu C; Zollinger DR; Madison RW; Fine AD; Gjoerup O; Rasola C; Angerilli V; Sharma S; Wu HT; Palsuledesai CC; Malhotra M; Aleshin A; Loupakis F; Renkonen E; Hegde P; Fassan M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232827
[TBL] [Abstract][Full Text] [Related]
10. Exploring immunotherapy in colorectal cancer.
Weng J; Li S; Zhu Z; Liu Q; Zhang R; Yang Y; Li X
J Hematol Oncol; 2022 Jul; 15(1):95. PubMed ID: 35842707
[TBL] [Abstract][Full Text] [Related]
11. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
13. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments.
Tang YL; Li DD; Duan JY; Sheng LM; Wang X
World J Gastroenterol; 2023 Feb; 29(6):926-948. PubMed ID: 36844139
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.
Maurel J; Postigo A
Curr Cancer Drug Targets; 2015; 15(8):703-15. PubMed ID: 26452385
[TBL] [Abstract][Full Text] [Related]
15. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem E; Cervantes A; Adam R; Sobrero A; Van Krieken JH; Aderka D; Aranda Aguilar E; Bardelli A; Benson A; Bodoky G; Ciardiello F; D'Hoore A; Diaz-Rubio E; Douillard JY; Ducreux M; Falcone A; Grothey A; Gruenberger T; Haustermans K; Heinemann V; Hoff P; Köhne CH; Labianca R; Laurent-Puig P; Ma B; Maughan T; Muro K; Normanno N; Österlund P; Oyen WJ; Papamichael D; Pentheroudakis G; Pfeiffer P; Price TJ; Punt C; Ricke J; Roth A; Salazar R; Scheithauer W; Schmoll HJ; Tabernero J; Taïeb J; Tejpar S; Wasan H; Yoshino T; Zaanan A; Arnold D
Ann Oncol; 2016 Aug; 27(8):1386-422. PubMed ID: 27380959
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis.
Ramadan M; Alfayea T; Alsofyani A; Alyabsi M; Alhusseini N; Algarni AS
Cancer Treat Res Commun; 2022; 33():100632. PubMed ID: 36088745
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of a Real-World Healthcare Claims Database.
Nakamura Y; Olsen S; Zhang N; Liao J; Yoshino T
Curr Oncol; 2022 May; 29(5):3433-3448. PubMed ID: 35621667
[TBL] [Abstract][Full Text] [Related]
18. Current and future targets and therapies in metastatic colorectal cancer.
Dzunic M; Petkovic I; Cvetanovic A; Vrbic S; Pejcic I
J BUON; 2019; 24(5):1785-1792. PubMed ID: 31786838
[TBL] [Abstract][Full Text] [Related]
19. Treatment sequencing in metastatic colorectal cancer.
Modest DP; Pant S; Sartore-Bianchi A
Eur J Cancer; 2019 Mar; 109():70-83. PubMed ID: 30690295
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development.
Gmeiner WH
Onco Targets Ther; 2021; 14():2121-2130. PubMed ID: 33790575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
